Clinical Trial Update: Bone Healing Accelerant Versus Standard of Care for Open Tibia Fractures [Phase 3]

View source ↗

Summary

Phase 3 trial investigating a bone healing accelerant for open tibia fractures has been withdrawn.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tibial Fractures

Snippet

Sponsor: Carmell Therapeutics Corporation | Conditions: Tibial Fractures | Phase 3 | Status: WITHDRAWN